BMS-986454 / BMS - LARVOL DELTA

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis (clinicaltrials.gov) - P1 | N=46 | Recruiting | Sponsor: Bristol-Myers Squibb | Not yet recruiting ➔ Recruiting

Enrollment open • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis (clinicaltrials.gov) - P1 | N=46 | Not yet recruiting | Sponsor: Bristol-Myers Squibb

New P1 trial • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology

A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants (clinicaltrials.gov) - P1 | N=63 | Completed | Sponsor: Bristol-Myers Squibb | Active, not recruiting ➔ Completed | Trial completion date: Mar 2026 ➔ Dec 2024 | Trial primary completion date: Mar 2026 ➔ Dec 2024

Trial completion • Trial completion date • Trial primary completion date

A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants (clinicaltrials.gov) - P1 | N=56 | Active, not recruiting | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Active, not recruiting | Trial completion date: Dec 2024 ➔ Mar 2026 | Trial primary completion date: Dec 2024 ➔ Mar 2026

Enrollment closed • Trial completion date • Trial primary completion date